Insights+

Insights+ Key Biosimilars Events of November 2022

Insights+ Key Biosimilars Events of November 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Top Performing Drug of 2021 – Xarelto (November Edition)

Top Performing Drug of 2021 – Xarelto (November Edition)

Active Ingredient: rivaroxaban  Strength: 2.5 mg, 10 mg, 15 mg, and...

Insights+: EMA Marketing Authorization of New Drugs in October 2022

Insights+: EMA Marketing Authorization of New Drugs in October 2022

The EMA approved 2 Biologic Drugs in October 2022, leading to treatments for patients and advances in the hea...

Insights+: The US FDA New Drug Approvals in October 2022

Insights+: The US FDA New Drug Approvals in October 2022

The US FDA approved 1 NDAs and 2 BLA in October 2022, leading to treatments for patients and advances in the...

Disease of the Month: Epilepsy | PharmaShots

Disease of the Month: Epilepsy | PharmaShots

INTRODUCTION Also known as seizure disorder, epilepsy is a non-communicable chronic disord...

Insights+ Key Biosimilars Events of October 2022

Insights+ Key Biosimilars Events of October 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Image